Latest news
Loading news…
Liminatus Pharma
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Wilmington, Delaware, United States Founded 2018 1-10 employees For Profit
Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
0
Ticker
LIMN
NASDAQ
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- LIMN
- Exchange
- NASDAQ
- IPO date
- Apr 30, 2025
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- IT spend
- $227K
Company Info
- Founded
- 2018
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 58
- HQ
- Wilmington, Delaware, United States
- Region
- Greater Philadelphia Area, East Coast, Southern US
- Exit date
- Apr 30, 2025
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -1
- Trend (30d)
- -1.9
- Trend (90d)
- 7
Acquisitions by Liminatus Pharma
Loading columns…
0 of 0Show
Page 1 / 1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Liminatus Pharma
Loading news…
FAQs about Liminatus Pharma
People who checked this page also checked these
Sectors Liminatus Pharma invests & acquires in
Browse the full Acquirezy directory.